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a  b  s  t  r  a  c  t
This  review  illustrates  current  applications  and  possible  future  directions  of  7  Tesla  (7 T)  Magnetic  Res-
onance  Imaging  (MRI)  in  the  ﬁeld  of brain  MRI,  in  clinical  studies  as  well  as  clinical  practice.  With  its
higher  signal-to-noise  (SNR)  and  contrast-to-noise  ratio  (CNR)  compared  to  lower  ﬁeld  strengths,  high
resolution,  contrast-rich  images  can  be  obtained  of  diverse  pathologies,  like  multiple  sclerosis  (MS),  brain
tumours,  aging-related  changes  and  cerebrovascular  diseases.  In  some  of  these  diseases,  additional  patho-
physiological  information  can be gained  compared  to lower  ﬁeld  strengths.  Because  of  clear  depiction
of  small  anatomical  details,  and  higher  lesion  conspicuousness,  earlier  diagnosis  and  start  of  treatmentrain anatomy
 T
of  brain  diseases  may  become  possible.  Furthermore,  additional  insight  into  the  pathogenesis  of  brain
diseases  obtained  with  7 T  MRI  could  be the  basis  for new  treatment  developments.  However,  imaging  at
high  ﬁeld  comes  with  several  limitations,  like  inhomogeneous  transmit  ﬁelds,  a  higher speciﬁc  absorp-
tion  rate  (SAR)  and,  currently,  extensive  contraindications  for patient  scanning.  Future  studies  will  be
aimed  at  assessing  the  advantages  and  disadvantages  of 7  T MRI  over  lower  ﬁeld  strengths  in  light  of
clinical  applications,  speciﬁcally  the  additional  diagnostic  and  prognostic  value  of 7  T  MRI.. Introduction
Magnetic Resonance Imaging (MRI) is a versatile technique to
mage changes in brain anatomy and function. Since its clinical
mergence in the beginning of the eighties, magnetic ﬁeld strength
or clinical MRI  has increased from <0.5 T to a wide use of 3.0 T
n current clinical practice today. Foremost, increase in signal to
oise and susceptibility induced contrast at higher ﬁeld strengths
s especially useful for imaging techniques that require a high
ignal-to-noise (SNR) and contrast-to-noise (CNR) ratio, such as
unctional imaging techniques (fMRI) and MR  spectroscopy, but
an also be used for high resolution anatomical imaging, including
-dimensional (3D) volume imaging, within acceptable scanning
ime. Although not widely used clinically at this point in time, an
ncreasing number of research sites worldwide have access to MRI
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scanners with a ﬁeld strength of 7.0 T. Most of the current research
on these 7 T MRI  platforms is related to hardware- and sequence
optimization to address some of the technical challenges of (ultra)
high ﬁeld imaging (inhomogeneous transmit ﬁeld, increased sus-
ceptibility artefacts, speciﬁc absorption rate (SAR) limitations).
To date only a few clinical studies have been performed at this
ultra-high ﬁeld strength, and there is an active debate in the MR
community [1,2] if and when 7 T MRI  may  become the ﬁeld strength
of choice for certain clinical applications.
The emphasis of most (technical) developments at 7 T lies on
imaging the brain. Functional imaging (BOLD) and techniques that
exploit susceptibility induced contrast are among the ones that
beneﬁt most from the ultra-high ﬁeld strength, and the arte-
facts in the brain are less pronounced than in other areas of the
body. However, a widespread acceptance of ultra-high ﬁeld imag-
ing as a clinical diagnostic instrument will require high quality
anatomical imaging sequences, like T1/T2-weighted, T∗2-weighted,
Fluid-Attenuated Inversion Recovery (FLAIR)-imaging and Mag-
netic Resonance Angiography (MRA). Combined with increased
SNR and CNR generated at these higher ﬁeld strengths, 7 T MRI  may
ﬁnd its way  to many improved and even new clinical applications.
Open access under the Elsevier OA license.Recently, a number of 3D anatomical sequences have been
developed and optimized that make optimal use of the increased
SNR at 7 T [3–6]. These sequences include FLAIR imaging, which
is an important sequence in most diagnostic standard brain MRI





























































Fig. 1. Within MRI, for a certain contrast there is a central trade-off between signal-
to-noise  ratio (SNR), resolution and imaging speed (faster imaging comes at the cost
of losing resolution and/or SNR, for example), which takes place within boundary
conditions imposed by the scanner, the subject and safety considerations. This graph
illustrates the changes (white arrows) that occur when the strength of the static ﬁeld
of the MRI scanner is increased (green arrow up). When the ﬁeld strength of the MRI
scanner is increased, the intrinsic SNR increases, which can be exchanged for either
increased imaging speed (e.g. by acquiring less averages) or increased resolution.
Since  the tissue relaxation parameters and the susceptibility effects depend on theA.G. van der Kolk et al. / European 
rotocols due to its high CNR between brain tissue lesions of any
ort and the surrounding healthy brain tissue. Although not as
mportant as the FLAIR sequence, T∗2-weighted MRI  sequences are
ncreasingly used in clinical MRI  protocols as well, for instance for
he detection of microbleeds. At 7 T, the larger susceptibility effect
ompared to MRI  at lower ﬁeld strengths may  result in new clinical
pplications of this sequence. Furthermore, T1-weighted imaging,
specially after contrast administration, can provide more detail to
ssess small pathology not seen as clearly at lower ﬁeld strength, for
nstance lesions of the intracranial vessel wall. Finally, MR  angiog-
aphy, which is regularly used in clinical practice to assess all kinds
f brain pathology, can be obtained with an ultra-high resolution
or optimal assessment of even smaller arteries of the brain than at
ower ﬁeld strengths, like the perforating lenticulostriate arteries.
Besides  increased costs and limited availability, disadvantages
or clinical use of 7 T MRI  include a range of imaging artefacts that
o date has prevented a further widespread dissemination of ultra-
igh ﬁeld MRI  for clinical diagnosis. Moreover, we still have to learn
ow normal anatomy and diseases look like with the changes in
ontrast and resolution at high ﬁeld. These could very well be the
ain reasons that the published literature on clinical research at
 T has thus far been limited. The aim of this current review article
s to show the clinical potential of 7 T MR  high-resolution anatom-
cal brain imaging based on the current state of the art imaging
latforms and the use of (high ﬁeld) dedicated pulse sequences.
dvanced hardware modiﬁcation (e.g. the use of multi-transmit
echnology), which undoubtedly will further improve the clinical
erformance of ultra-high ﬁeld imaging, is beyond the scope of this
eview. Apart from a review of the current literature, a series of
llustrative patient examples will be included.
. Technical aspects of high ﬁeld 7 T imaging
For  a given contrast, the three fundamental factors that
etermine the design and applications of MR  imaging are: signal-
o-noise ratio (SNR), imaging speed, and spatial resolution (Fig. 1).
hese factors are all related, and changing one of them will affect
he other two parameters and vice versa. This provides ﬂexibil-
ty to utilize the increased intrinsic SNR at high ﬁeld, which rises
pproximately linearly with ﬁeld strength. Within boundary condi-
ions (like limits on tissue heating), the increased SNR can be used
or either better lesion conspicuousness, or for increasing imag-
ng speed to reduce motion artefacts (which facilitates imaging of
nstable or less cooperative patients), or for increasing the spa-
ial resolution to identify smaller pathological lesions. Even though
any pathological processes in the brain in daily clinical routine
an be detected with lower-resolution images, one can think of
any applications where higher resolution could be beneﬁcial.
igh-resolution imaging could make it possible to detect brain
iseases in an early stage, by visualizing very small pathological
hanges. Furthermore, the pathological basis and development of
rain diseases could be further elucidated by more detailed imag-
ng.
High magnetic ﬁeld strength also affects the relaxation times
f tissues, T1 and T∗2 in particular [7]. Fortunately, as shown by
ooney et al. [8], the increased longitudinal relaxation times still
llow for sufﬁcient contrast between grey and white matter in T1-
eighted brain imaging. Even more so, as the T1-values for grey and
hite matter increase from 1.5 T to 7 T from 1188 ms and 656 ms
o 2132 ms  and 1220 ms,  respectively [8], high ﬁeld imaging can be
sed to generate exquisite Time-Of-Flight MR  Angiography (TOF-
RA) with a high contrast-to-noise. In TOF-MRA, tissues with static
pins become excited several times by radiofrequency (RF) pulses
ithin their relaxation time T1, and become saturated. Non-excited
owing blood that enters the exited volume, on the other hand,ﬁeld strength, also the contrasts will change at higher ﬁeld. Challenges are imposed
by  the increased inhomogeneity of both the main ﬁeld (B0) and the RF transmit ﬁeld
(B1), together with an increase in SAR.
will be excited for only a limited number of times, depending on
the chosen slab volume, resulting in a high signal. For a given pulse
angle, when the T1 relaxation times of tissues become longer, the
static spins will relax less in between the RF pulses, resulting in
lower signal of static tissue, and hence in a better contrast between
suppressed background and ﬂowing blood.
The shortened T∗2-values are related to the increased mag-
netic susceptibility effects that scale linearly with magnetic ﬁeld
strength, while T2-value changes will be not as pronounced. Also,
the magnetic susceptibility effects of tissues at higher ﬁeld cause
more distortion of the local magnetic ﬁeld in its surrounding.
Especially, paramagnetic and diamagnetic substances like deoxy-
haemoglobin (veins), calcium (calciﬁed tumour), blood degradation
products (like haemosiderin in microbleeds), iron-depositions
and air (air-ﬁlled cavities) will exert this effect. Although these
enhanced susceptibility effects may  cause image distortions and/or
local signal drop-outs (due to dephasing), it also gives the opportu-
nity of creating better tissue contrast. This can be readily visualized
with a T∗2-weighted sequence sensitive for susceptibility effects.
Besides these intrinsic MR  characteristics of tissue that change
as a function of ﬁeld strength, there are certain conditions that
impose a boundary condition for the design and application for
diagnostic high-ﬁeld imaging protocols. Because of the larger mag-
netic susceptibility effects seen at high ﬁeld strength, metallic
objects like surgical implants, and air such as in the nasal cavities,
will cause much more image distortion and artefacts (signal drop-
out) than at lower ﬁeld strengths for a given receive bandwidth.
Possible temperature effects in conducting implant materials are
another impediment for the widespread clinical use of high-ﬁeld
imaging. Obviously, these effects impose strict safety measures for
MRI  at all ﬁeld strengths and, albeit much more pronounced at
high ﬁeld, should be taken into consideration in all MRI applica-
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mplants have when placed in a high magnetic ﬁeld: most stud-
es on safety of metallic objects have been performed at 1.5 or
 T. Safety precautions regarding 7 T MRI  so far state that noth-
ng metallic should enter the bore, since it would be expected that
he shorter wavelength at 7 T ‘matches’ more easily with metallic
bjects, causing resonance and heating. Currently, this is the major
ontraindication when conducting patient studies at 7 T. Although
atients can be screened for the presence of for instance dental
rostheses, it is very laboursome, and often practically impossi-
le to track if operation clips or other metallic implants like stents
ave been used for patients with a history of surgery, and if these
ype of clips or stents are safe. Also, in elderly patients, especially
atients with atherosclerosis-related diseases such as stroke, the
resence of stents in the heart, aorta or leg vasculature is common
nd not always speciﬁcally documented if implanted a long time
go. To illustrate the size of the current problem, in a recent stroke
tudy we had to exclude 173 of 611 eligible stroke- or transient
schemic attack (TIA)-patients due to 7 T MRI  contraindications [9].
afety testing of most often used operation clips, stents and dental
mplants is important to decrease the present list of contraindica-
ions.
Finally, at high magnetic ﬁeld, severe inhomogeneity in the
pplied transmit ﬁeld (RF ﬁeld) is seen. Because of this inhomo-
eneity, the achieved pulse angle will vary between locations in the
rain. This results in a spatially varying SNR [10]. More importantly,
nd dependent on the sequence that is used, this might lead to devi-
tion of the contrast obtained from different locations in the image.
hese effects are most pronounced at the temporal lobes of the
rain and the cerebellum. Therefore, in the peripheral areas of the
rain assessment of anatomical structures and possible pathology is
urrently difﬁcult. Furthermore, the inhomogeneous transmit ﬁeld
auses additional SAR restrictions. The global SAR (mean SAR over
 certain volume) increases approximately with the square of the
pplied magnetic ﬁeld strength. However, because of the inhomo-
eneities of the transmit ﬁeld, the SAR is also less homogeneously
istributed over the brain [11], causing larger differences between
reas and higher SAR peaks at speciﬁc places, further imposing
tringent limitations on the duty cycle of the applied sequences. The
hallenges in the transmit ﬁeld can be addressed with new hard-
are approaches as well as improved pulse sequence design. This
eview will describe MRI  applications based on this latter approach
nly to present data that can be obtained by most clinical 7 T plat-
orms today.
.  Clinical 7 T studies in the literature
The four most important disease areas in the literature studied
ith 7 T MRI  are multiple sclerosis (MS), cerebrovascular dis-
ases (microbleeds, aneurysms), brain tumours, and degenerative
iseases like dementia and Parkinson’s disease. In MS  studies,
he detection of (sub)cortical lesions is important in unravel-
ing the pathogenesis of MS  lesions in general. In cerebrovascular
iseases most attention is paid to MR  angiography at high reso-
ution to show small (lenticulostriate) arteries feeding the deep
rain structures. Also, the role of microbleeds in this disease cate-
ory has been studied quite extensively. In tumour patients most
ttention is paid to visualization of the microvasculature with
∗
2-weighted imaging. For degenerative diseases like dementia,
linical 7 T MRI  studies mainly focus on technical developments
or high-resolution imaging of the hippocampus. The current state
f research and potential future directions within these clini-
al ﬁelds will be discussed below. Furthermore, the status of 7 T
RI  in other areas like epilepsy and accidental ﬁndings will be
iscussed.l of Radiology 82 (2013) 708– 718
3.1. Multiple sclerosis
Since  the introduction of MR  imaging in human clinical practice,
multiple sclerosis (MS) has always been a prominent application
ﬁeld for new MR  sequences and other technical developments.
Several reasons could explain this interest, like the availability of
clinical follow-up, participation in other studies simplifying contact
and inclusion, and the relative young age of MS  patients (20–30 s)
decreasing the prevalence of contraindications for MRI  such as
metallic implants. Another important reason might be the often
difﬁcult diagnosis of this disease, heightening the need for new
diagnostic imaging modalities. MS  is a demyelinating disease with
a currently almost unknown pathogenesis, and few evidence-based
measurable biomarkers which can be used to predict both disease
course and treatment effect. Most applications of MRI  in the assess-
ment of MS  have focused on imaging white matter lesions, one of
the possible hallmarks of MS.  Although white matter lesions can be
found at lower ﬁeld strength throughout the brain, cortical lesions
remain a challenge because of the lower resolution that can be
attained at lower ﬁeld strength, and the reduced contrast between
the lesion and its surrounding tissue. However, recent work has
shown that these cortical lesions could be of particular importance
to gain more insight into the pathogenesis of MS  [12].
Moving to high-ﬁeld MRI  could provide the spatial resolution
and CNR needed to visualize these cortical lesions with higher pre-
cision. However, the main sequences that are used for imaging
MS lesions at lower ﬁeld strengths are FLAIR or double inversion-
recovery (DIR). These sequences are not easily implemented at
higher ﬁeld, like 7 T MRI, and require rigorous sequence changes.
Recently, our group have shown the availability of a new 3D FLAIR-
sequence at 7 T [3,13], offering the opportunity to study lesions
with high anatomical detail, possibly giving more insight into
the pathological processes of MS.  Recent work by de Graaf et al.
[14] has shown the better conspicuity of MS  lesions at 7 T FLAIR
compared to 3 T FLAIR MRI  (Fig. 2). Several studies showed the pos-
sibility of imaging cortical MS  lesions with other high-resolution
sequences, like T∗2-weighted, double inversion recovery (DIR) and
MPRAGE imaging [15–18]. Some lesions were shown to possess
additional characteristics like peripheral susceptibility rings not
seen before on lower ﬁeld strengths [15,16]. Possibly detection
of cortical lesions and other hallmark features may increase the
correlation between clinical disease progression and MRI  imaging
features, although no such study has been performed yet.
Apart  from these recent advances in FLAIR-imaging and in imag-
ing cortical lesions, several studies have shown with T∗2-weighted
imaging a relationship between veins and the presence of MS-
related white matter lesions [19–22]. In MS-related white matter
lesions, veins were found in 80–85% of patients compared to
10–20% in normal-aging-related white matter lesions [21,22].
From a pathophysiological point of view this association between
white matter lesions and (central) veins might be important,
although from previous studies at lower ﬁeld strength as well
as post-mortem studies this relation has already been known
[23]. Comparison between 7 T and 3 T MRI  showed that the rela-
tion between veins and MS-related white matter lesions was
more clear at 7 T with a higher percentage of lesions showing a
vein with T∗2-weighted imaging [21]. In this regard detection of
a central vein within a lesion may  help in deﬁnitively diagnos-
ing MS  when the diagnosis is uncertain, although no study yet
has proven that 7 T MRI  is better in diagnosing MS  compared to
3 T MRI.3.2.  Cerebrovascular diseases
Clinical  studies within the ﬁeld of cerebrovascular diseases
have mainly focused on high-resolution MRA  and imaging of
A.G. van der Kolk et al. / European Journa
Fig. 2. 63-year-old female with primary progressive multiple sclerosis (MS) with
an Expanded Disability Status Score (EDSS) of approximately 6.0. A 7 T MRI  scan
was  performed for the detection of possible cortical lesions. a, Axial overview and
b, zoomed-in image of a high parietal cortical MS  lesion (right arrow) on axial 7 T
3D-FLAIR sequence. In retrospect, this lesion could also be seen on the 3 T 3D-FLAIR
images,  although with lower contrast-to-noise (c). The other cortical lesion (left
arrow) on the other hand could not be seen at 3 T MRI. Imaging parameters 7 T 3D-

























dourtesy of W.L. de Graaf, VUmc Amsterdam, The Netherlands.
icrobleeds with T∗2-weighted sequences. Following the devel-
pment  of high resolution MRA  at 7 T, which could show
enticulostriate arterial branches [24–26], these methods have
een applied in patient studies. The lenticulostriate arteries are
he small arterial branches which feed the deep brain structures
uch as the basal ganglia. The presence of lacunar infarcts in
hese areas is thought to be related to the pathological state of
hese small arteries, also referred to as small vessel disease [27].
hus far, small vessel disease could almost solely be inferred
ndirectly from the presence of white matter lesions and lacu-
ar infarcts which are thought to be imaging markers for the
resence and severity of disease of the small arterial vascula-
ure [27]. Because of its high SNR and, thereby, its possibility to
mage at a high spatial resolution, 7 T made it possible to visualize
ore direct markers for small vessel disease, i.e. the pathological
rteries themselves. This has therefore been an increasing ﬁeld of
nterest. In one study the number and conﬁguration of lenticulos-
riate arteries was compared between controls and chronic stroke
atients, who showed less arteries than the control group [28].
n patients with hypertension the number of visible lenticulos-
riate arteries was also found to be smaller compared to controls
29]. In patients with CADASIL these arteries were not found to
iffer from control subjects even in the presence of severe whitel of Radiology 82 (2013) 708– 718 711
matter  lesions or lacunar infarcts [30]. It should be realized that,
although 7 T MRI  can show the perforating arteries over a cer-
tain length, these arteries are still large-sized arteries compared
to the even smaller resistance arterioles, which are still out of
reach of inﬂow-based MRA  methods. It is therefore possible that
the small artery disease causing white matter lesions and smaller
lacunar infarcts is currently still out of reach of the available 7 T MRI
methods.
The appearance of aneurysms can also be assessed with high-
resolution MRA, where studies [31,32] have shown the clear
depiction of characteristics of the aneurysm including the presence
of small perforating branches. These branches, when originating
from the aneurysm, could potentially result in an infarct if not
noticed when planning treatment, for instance clipping of the
aneurysm. Only two studies have compared 1.5 T and 7 T TOF-MRA
for the conspicuousness of aneurysms, where the image quality
was rated better at 7 T [31,32]. However, in terms of sensitivity for
the detection of small aneurysms, no comparisons have been made
with 1.5 T and 3 T MRI, and it has therefore yet to be determined if
7 T MRI  may  detect more clinically relevant aneurysms. For follow-
up of treated aneurysms 7 T MRI  is currently not possible due to the
contraindications of clips and coils.
In the last decade, microbleeds have attracted more and more
attention, especially at higher ﬁeld strengths like 3 T and 7 T MRI.
Due to their paramagnetic nature – consisting of blood break-
down products – microbleeds can be successfully visualized using
T∗2-weighted imaging. The increased sensitivity of higher ﬁeld MRI
for microbleeds is caused both by the increased susceptibility effect
at a higher magnetic ﬁeld strength, and by the increased spatial
resolution that can be attained. Because of the large suscepti-
bility effect at 7 T, visualization of microbleeds is possible even
with very short echo times (TE), retaining most of the background
signal and causing a large CNR. For example, in some healthy
volunteer-studies microbleeds were even visible at TE = 2.5 ms  [33].
By increasing spatial resolution, even smaller microbleeds can also
be visualized. With lower resolution, and often lower ﬁeld strength,
the slight hypointensity of small microbleeds may  be lost in the
noise. It has been found that detection of microbleeds was  superior
at 7 T compared to 1.5 T MRI  [34].
Microbleeds may show the pathophysiology of small vessel dis-
ease from a different angle compared to white matter lesions and
lacunar infarcts. Second, they could be a marker for increased risk
of bleeding when an ischemic stroke is treated with intravenous
thrombolysis. Furthermore, microbleeds may also be related to
the presence of hypertension. In a 7 T MRI  case example microb-
leeds were found to be located close to lenticulostriate arteries
in a patient with a hypertensive haemorrhage [35]. However, the
exact cause of (very small) microbleeds detected with 7 T MRI,
and their role in cerebrovascular diseases needs to be further
elucidated before clinical implementation, especially at 7 T, can
be commenced. Although short echo times are advantageous for
assessing microbleeds, with longer echo times the strong suscepti-
bility effect of veins can be used to make venograms, and assess the
venous tree and its relation to pathology like microbleeds in more
detail.
Another area that has attracted more interest in the last few
years is the presence of intracranial atherosclerosis. Visualization
of the arterial lumen only gives information regarding possible
stenosis, but does not give information regarding the nature of
this stenosis; for this you need to visualize the intracranial ves-
sel wall itself. At 1.5 T and 3 T MRI  the intracranial vessel wall could
only be depicted when large atherosclerotic lesions or a vasculi-
tis was present [36–38]. The high SNR at 7 T may  be exploited
for an increased resolution that makes it possible to depict this
intracranial vessel wall. A study with 7 T MRI  showed visualization
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tudies could show whether intracranial atherosclerotic lesions
ave a higher prevalence in patients who suffered from a stroke
r transient ischemic attack [9].
.3. Degenerative brain diseases
7 T MRI  in degenerative diseases has so far focused on two
ubjects: dementia (Alzheimer’s disease (AD) and vascular demen-
ia) and Parkinson’s disease. One study assessed the association
etween vascular dementia and the presence of white matter
esions and microbleeds on T∗2-weighted and FLAIR imaging, where
 T could potentially improve detection, diagnosis and treatment
f vascular dementia with T∗2-weighted sequences [39]. Cerebral
icrobleeds may  be present as part of the spectrum of cerebral
myloid angiopathy [40]. Although potentially important, the real
rognostic value of microbleeds in patients with dementia and
lzheimer’s disease has yet to be determined.
The holy grail of 7 T MRI  in degenerative brain diseases is
he direct detection of amyloid plaques. Very sensitive imaging
ethods such as T∗2-weighted imaging employed at a very high
esolution may  show changes in the brain tissue that may  be
elated to the presence of amyloid. In a post-mortem study 7 T MRI
howed the presence of such very small tissue changes in the cere-
ral cortex [41]. Still, it is not clear if the (cortical) tissue changes
etected in post-mortem studies can be reproduced in patient stud-
es where shorter imaging times (i.e. lower spatial resolution) and
atient motion are potential problems that should be overcome
42].
Other studies on dementia focus on evaluation of the detailed
ubstructures of the hippocampus. In several comparative stud-
es it has been shown that 7 T MRI  can show more anatomical
etail in the hippocampus compared to 1.5 T [43] and 3 T [44]
RI, by means of higher contrast between grey and white matter
ubstructures. The detection of these substructures may  be impor-
ant because changes in the hippocampus associated with memory
oss may  be more pronounced in speciﬁc areas of the hippocam-
us. Currently it is not clear which 7 T MRI  sequence(s) is (are)
est in showing these substructures, although T1-, FLAIR, T∗2- and
2-weighted imaging at high resolution showed promises in this
egard [4,43,44]. Based on lower clinical ﬁeld strengths it can be
xpected that coronal FLAIR-based imaging approaches may  be
f value. Still, for 7 T MRI  the medial temporal lobe and the hip-
ocampus are located in a difﬁcult area of the brain in which ﬁeld
nhomogeneities are often present and SAR-constraints may  limit
mage quality. Already with the currently available imaging meth-
ds, differences in hippocampal substructures between control
ubjects and patients with probable AD were demonstrated [44].
rom a pathophysiological point of view imaging of these differ-
nces may  be important in understanding which substructures of
he hippocampus are involved in memory loss in dementia and AD,
ncluding the role they play in the pathogenesis and their possible
ole as marker for progression to AD in patients with minor memory
omplaints.
Finally, several studies with 7 T MRI  have been performed in
atients with Parkinson’s disease (PD), directed at imaging deep
rain stimulation targets, like the subthalamic nucleus and internal
lobus pallidus, and at visualization of the substantia nigra, thought
o play a primary role in the pathogenesis of PD. Treatment of PD by
eans of deep brain stimulation depends greatly on correct posi-
ioning of the stimulating electrode in the target areas. Cho et al.
45] showed that 7 T MRI  was superior in delineating these areas
ompared to 1.5 T and 3.0 T. Bajaj et al. [46] showed that 7 T MRI
ould distinguish subregions of the substantia nigra, and found an
ncreased iron content in a part of this basal ganglion in PD patients
ompared to healthy volunteers. Recently, Oh et al. [47] visualized
ifferences in anatomical patterns of the substantia nigra betweenl of Radiology 82 (2013) 708– 718
healthy  controls and PD patients with 7 T MRI, possibly enabling
earlier diagnosis of PD.
3.4.  Brain tumours
In  clinical brain tumour imaging the presence or absence
of MRI-enhancement after administration of a gadolinium-based
contrast agent is still the most import imaging marker to discrim-
inate between low- and high-grade tumours. Although distinction
between tumour grades with this marker is not perfect, as a gen-
eral rule low-grade brain tumours show no contrast enhancement
in comparison to high-grade tumours. This contrast enhancement
is predominantly caused by blood–brain-barrier disruption with
subsequent contrast leakage. Better tumour grading and character-
ization may  be relevant for treatment planning and guiding biopsy.
It is well known that brain tumours are heterogeneous and, depend-
ing on the location a biopsy is taken, a different tumour grade
may be found. With respect to tumour enhancement comparisons
between 7 T MRI  and lower ﬁeld strengths have shown no differ-
ences in presence and size of the enhancing region after contrast
administration [48,49]. With other MRI  methods like T∗2-weighted
imaging, 7 T may  provide additional information relative to 3 T and
1.5 T MRI. For instance, 7 T MRI  may  show details of the arterial
cerebral microvasculature in brain tumours [48,49], and provide
additional information regarding delineation of more rare tumours
[50]. Venography by means of T∗2-weighted imaging may  pro-
vide information about tumour metabolism, since the increased
metabolism in a brain tumour may  result in increased oxygen con-
sumption resulting in more deoxyhaemoglobin and therefore more
pronounced veins on T∗2-weighted MRI  sequences.
There  are still unexplored areas within the ﬁeld of brain tumour
imaging that could be of potential interest to researchers work-
ing with 7 T MRI. Expansion of tumour in areas surrounding the
tumour core is difﬁcult to assess with standard MRI  methods. It
is well known, based on tumour recurrence after treatment, that
areas surrounding the tumour core are also inﬁltrated by tumour
tissue. In these areas oedema is usually present, which is visu-
alized as high signal on T2-weighted imaging sequences such as
T2-weighted FLAIR MRI. If new imaging methods at 7 T could help
determine the extent of tumour inﬁltration in these surrounding
areas of oedema, this could be very important for a more aggres-
sive treatment of these areas (surgically or with radiotherapy) to
avoid tumour recurrence after initial treatment. Also, differentia-
tion between necrotic primary brain tumours, necrotic metastases
and cerebral abscesses with current imaging techniques is still a
diagnostic dilemma. All three show ring-like enhancement after
contrast administration, and often have the same characteristics
on for instance diffusion-weighted imaging. Using new sequences
at 7 T with different contrasts compared to lower ﬁeld strength,
might show promise in further elucidating differences between
these three pathologically very different entities. Furthermore,
after initial treatment an important area of diagnostic uncertainty is
the differentiation between radionecrosis and tumour recurrence.
Both radionecrosis (a treatment effect) and tumour recurrence can
show enhancement after contrast administration. Although sev-
eral MRI  methods have been developed at lower ﬁeld strength
for the differentiation between both entities [51], there may  be
room for improvements of these methods. Unfortunately, the post-
operative status of patients with this diagnostic dilemma (metal
cranioﬁxatives, etc.) hampers performing potentially interesting
patient studies on the differentiation between radionecrosis and
tumour recurrence with newly developed 7 T MRI methods. Cur-
rently, only initial studies have been performed in smaller series of
brain tumour patients at 7 T [48–50,52] and it is not clear yet if 7 T
MRI  can solve important issues such as tumour inﬁltration better
than existing MRI  methods at lower ﬁeld strengths.
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Fig. 3. 77-year-old man with a history of hypertension presented with transient dysphasia based on a transient ischemic attack (TIA) of the left hemisphere. a, c, Axial
minimal intensity projections (minMIPs) over 10 mm thick volumes of the 1st and b, d, minMIPs of the 2nd echo of 7 T T∗2-weighted images, where multiple microbleeds can
be found throughout the brain (arrows). Some are less easily distinguished on the 2nd echo minMIPs due to overlapping venous structures (striped arrows) and artefacts
close to the nasal cavity. e, Zoomed-in image of 7 T and f, of standard clinical 1.5 T 1st echo minMIPs, showing better visualization of the microbleeds due to the increased
susceptibility effects at 7 T compared to 1.5 T MRI. Imaging parameters as previously published [33].
Courtesy of Dr. M.M.  Conijn, VUmc Amsterdam, The Netherlands.
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Fig. 4. 62-year-old female with a history of smoking and hyperlipidemia presented with transient monocular visual ﬁeld defect of the left eye, based on amaurosis fugax. a,
b,  Axial MPIR-TSE images, showing healthy intracranial arterial vessel wall of both internal carotid arteries and basilar artery (a, arrows), as well as the M1 of the right middle
cerebral artery (b, arrow) and the basilar artery-posterior cerebral artery bifurcation (b, arrow). Imaging parameters as previously published [9], 0.8 mm isotropic resolution.











(otor dysphasia. a–c, Axial standard clinical 1.5 T and d–f, corresponding 7 T MRI  FL
arrows). Due to the higher contrast-to-noise ratio at 7 T, lesions were more conspi
n  c, compared to f). Imaging parameters as previously published [3], 0.8 mm isotro
.5. Epilepsy
7  T MRI  may  give additional diagnostic information in patients
ith cryptogenic epilepsy in which no structural epileptic focus
an be found at 3 T and 1.5 T. With the improved SNR and possi-
ility of scanning at a high spatial resolution, it may  be possible to
ig. 6. 42-year-old man  with blank medical history presented with searing headache and
he  right middle cerebral artery (MCA)-territory. a, Axial CT-image showing slightly hypo
f  the right MCA. b, Axial minMIP (over 10 mm thick volume) of the 1st and c, the 2nd 
arrows). Due to the very short T∗2 of thrombus, it can already be seen on the 1st echo minages, showing several small cortical and subcortical hyperintense ischemic lesions
 than at lower ﬁeld strength, and some were seen only in retrospect at 1.5 T (arrow
solution.
detect  small areas of cortical dysplasia at 7 T MRI  which may  have
been missed at lower ﬁeld strengths, although no such studies have
been performed thus far. There are however a few studies which
focus on other causes of epilepsy, like cerebral cavernous haeman-
giomas (CCHs) and hippocampal sclerosis. Two studies assessed
CCHs with T∗2-weighted imaging at 7 T MRI  [53,54], of which one
 thereafter hemiparesis of the left arm and leg, based on an ischemic infarction of
dense signal of the right temporal lobe, as well as a hyperdense vessel sign (arrow)
echo of 7 T T∗2-weighted images, visualizing thrombotic material in the right MCA
MIP (b). Imaging parameters of the 7 T T∗2-sequence as previously published [33].
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Fig. 7. Coronal images of two  healthy volunteers of 41 (a, b) and 77 years old (c, d), showing the head and body of the hippocampus. Although the hippocampal substructures
are more readily appreciated in the older volunteer (c, d) due to better contrast between the hippocampal substructures and enlarged cerebrospinal ﬂuid spaces, also in the
young  volunteer hippocampal substructures can easily be discerned (a, b). Several cortical and subcortical foldings can be identiﬁed in both hippocampi and cortical layers.
Imaging parameters were TR 3158 ms,  TE 271 ms,  TSE factor 181, NSA 2, resolution 0.6 mm × 0.7 mm × 0.7 mm.
Fig. 8. A 32-year-old male presented with symptomatic therapy-resistant epilepsy characterized by recurrent partial secondary generalized seizures and recurrent status
epilepticus. a, Standard clinical 1.5 T T1-weighted and c, FLAIR image, with corresponding images at 7 T MRI  (b, d). Both imaging sequences at both ﬁeld strengths could
visualize focal cortical dysplasia medially in the right frontal hemisphere (arrows in a–d). However, due to the higher contrast at 7 T, the focal lesion was more pronounced at
the  7 T FLAIR image (d). Imaging parameters of the 7 T FLAIR-sequence as previously published [3]; 7 T T1-weighted sequence: shot interval 3500 ms,  TI 1200 ms,  TR 7.0 ms,
TE  2.9 ms,  0.8 mm isotropic resolution.
Courtesy  of Dr. C.H. Ferrier, UMC  Utrecht, The Netherlands.
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Fig. 9. a–c, Axial 1st echo minMIPs (over 10 mm thick volumes) of T∗2-weighted 7 T MR images of a 22-year-old healthy female volunteer showing a developmental venous
anomaly, a benign condition not requiring any treatment if asymptomatic [58]. Due to the increased susceptibility effect of venous deoxygenated blood at high magnetic
ﬁeld, the venous structure can be assessed even at a TE = 2.5 ms,  as well as its various branches (arrow in a–c). Imaging parameters as previously published [33].
Fig. 10. a–c, Axial reformats of a 3D FLAIR dataset of a 26-year-old healthy female volunteer, showing, among others, the basal ganglia, choroid plexus (hyperintense signals
in  the ventricles) and the corticospinal tract (arrows) as it ascends to form the internal capsule (b) and then fans out throughout both hemispheres (c). Imaging parameters
as previously published [3], 0.8 mm isotropic resolution.
Fig. 11. 61-year-old male with a blank medical history presented with mild dysphasia and hemiparesis of his right arm and leg based on an ischemic stroke of the left
hemisphere. a–c, Axial standard clinical 1.5 T and d–f, 7 T T2-weighted MR images, showing the ischemic area at the transition corona radiata – internal capsule (arrows
in a and d), which can be more easily appreciated at the 7 T images (d). Furthermore, several hyperintense structures can be seen on both 1.5 and 7 T localized to the left
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tudy compared their results with images obtained at 1.5 T MRI
53]. They found that 7 T MRI  resulted in identiﬁcation of more
avernomas than at 1.5 T, suggesting that 7 T MRI  might be of addi-
ional diagnostic value [53]. Another study compared 1.5 T with
 T MRI  for imaging hippocampal sclerosis, and found that 7 T pro-
ided better delineation of anatomical hippocampal structures by
eans of strong contrast, potentially improving detection of struc-
ural changes causing epileptic seizures [55]. An initial study with
ostoperative specimens with focal cortical dysplasia showed the
orrelation between 7 T MRI  ﬁndings and pathology [56]. Future
tudies will show the additional diagnostic value of 7 T MRI  in
etection of epileptic lesions not currently seen at lower ﬁeld
trengths.
.6. Other diseases and accidental ﬁndings
7 T MRI  may  also be of beneﬁt in more generalized changes of
he brain, for instance less speciﬁc changes associated with aging.
he most obvious changes associated with aging are atrophy and
ncreased white matter lesions and (silent) infarcts. 7 T MRI  with
igh resolution imaging of the cerebral cortex may  show more
learly the extent of changes in the brain tissue, even in brain
egions that may  appear normal at 3 T and 1.5 T MRI. Furthermore,
etection of associated changes in or close to the brain vascula-
ure may  give clues as to possible causes of brain tissue changes
ssociated with aging. In addition to aging-related ﬁndings, the
umber of chance ﬁndings may  also increase when performing
 T MRI  with a high spatial resolution. Especially with T∗2-weighted
maging, detection of developmental venous anomalies (DVAs) may
ncrease due to the more pronounced visualization of the veins at
 T. These and other clearly benign lesions should not be mistaken
or pathology. Finally, for radiologists the different tissue contrasts
t 7 T may  result in a learning curve to ﬁnd out a new normal refer-
nce. For instance the basal ganglia and the white matter may  show
ore extensive internal structures at 7 T MRI  that are not present
t lower ﬁeld strengths [57].
. Case series
Illustrative case examples of patients within the previously
entioned disease categories can be found in Figs. 2–11. All
atients gave written informed consent to be scanned at 7 T MRI  at
he University Medical Center Utrecht, The Netherlands, in accor-
ance with the guidelines of our institutional review board. All 7 T
maging was performed on a 7.0 T whole body MRI  scanner (Philips
ealthcare, Cleveland, OH, USA) with a 16 channel receive coil
nd volume transmit/receive coil for transmission (Nova Medical,
ilmington, MA,  USA).
.  Conclusions
The ﬁeld of clinical 7 T MRI  of the brain is moving for-
ard quickly, and several technical developments, like 7 T FLAIR,
∗
2-weighted imaging and high-resolution MRA, have the potential
f being applied in the near future in various disease categories.
sing the high SNR and CNR obtained with high ﬁeld imaging,
e may  gain important insights that at present are not obtained
ith lower ﬁeld strengths, regarding the pathophysiology, diag-
osis, and treatment of several disease entities, such as MS,  brain
umours, and epilepsy. It is, however, important to determine
he actual diagnostic and prognostic value of these new ﬁndings
btained with 7 T MRI. Especially, the advantages of high ﬁeld imag-
ng for clinical diagnosis and treatment should be weighted against
he potential disadvantages of inhomogeneous transmit ﬁelds and
atient contraindications. In this regard, studies comparing 7 T MRI
[l of Radiology 82 (2013) 708– 718 717
with  imaging at lower ﬁeld strengths will be needed to address this
clinically relevant question.
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